Zhu, Qian-Ying
Shan, Sisi http://orcid.org/0000-0002-7184-6818
Yu, Jinfang http://orcid.org/0000-0002-2294-0752
Peng, Si-Ying
Sun, Cong http://orcid.org/0000-0003-1786-7420
Zuo, Yanan
Zhong, Lan-Yi
Yan, Shu-Mei
Zhang, Xiao
Yang, Ziqing
Peng, Yong-Jian
Shi, Xuanling
Cao, Su-Mei
Wang, Xinquan http://orcid.org/0000-0003-3136-8070
Zeng, Mu-Sheng http://orcid.org/0000-0003-3509-5591
Zhang, Linqi http://orcid.org/0000-0003-4931-509X
Funding for this research was provided by:
Beijing Municipal Science and Technology Commission (D171100000517003, D171100000517001)
Article History
Received: 20 January 2021
Accepted: 26 October 2021
First Online: 16 November 2021
Competing interests
: The authors declare the following competing interests: Patent applications have been filed on monoclonal antibodies that cover 1D8 presented here (patent application number: CN202010363336.X; patent applicants: Sun Yat-sen University Cancer Center and Tsinghua University). Q.Z., S.S., S.C., L.Z., and M.Z. are the inventors. All other authors declare no competing interests.